Point72 »

Protalix Biotherapeutics shares owned by Point72

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 12k 1.02

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Protalix Biotherapeutics

Renaissance Technologies
Goldman Sachs Group
GSA Capital Partners
BlackRock
Stratos Wealth Partners
Bridgeway Capital Management
BlackRock
Citadel Advisors
Squarepoint Ops
Qube Research & Technologies
Morgan Stanley
Susquehanna International
Orin Green Financial
Two Sigma Securities
Northern Trust

View all funds holding Protalix Biotherapeutics